BeOne Medicines Quarterly Balance Sheet
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BeOne Medicines financial position
As of Jun 30, 2026, BeOne Medicines reported total assets of $9.18 billion, up 45.7% from a year earlier against total liabilities of $4.00 billion. Shareholders' equity stood at $5.17 billion, or 56.4% of assets. The company held $5.10 billion in cash and equivalents against $1.14 billion of debt, a net cash position of $3.95 billion.
The current ratio (current assets divided by current liabilities) was 3.40, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.22.
Summary generated from market data by MetaCap's automated system. Methodology
BeOne Medicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.10B | 4.79B | 4.55B | 4.04B | 2.76B | 2.52B | 2.63B | 2.70B | 2.59B | 2.79B | 3.17B | 3.07B |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | — | 2.60M | — |
| Receivables | 1.06B | 938.02M | 865.08M | 863.28M | 770.78M | 717.24M | 676.28M | 569.05M | 529.45M | 435.29M | 358.03M | 309.08M |
| Inventory | 732.60M | 681.59M | 608.23M | 531.69M | 502.87M | 494.66M | 494.99M | 431.68M | 443.26M | 447.35M | 416.12M | 316.93M |
| Total Current Assets | 7.22B | 6.60B | 6.23B | 5.66B | 4.31B | 3.90B | 3.99B | 3.91B | 3.84B | 3.91B | 4.20B | 4.05B |
| Property, Plant & Equipment | 1.64B | 1.64B | 1.64B | 1.63B | 1.62B | 1.60B | 1.58B | 1.56B | 1.52B | 1.42B | 1.32B | 1.18B |
| Intangible Assets | 60.96M | 61.68M | 62.70M | 63.58M | 64.89M | 50.14M | 51.09M | 53.94M | 53.72M | 55.17M | 57.14M | 53.66M |
| Long-Term Investments | 66.06M | 65.98M | 61.68M | 100.65M | 119.47M | 121.14M | 128.93M | 138.23M | 139.77M | 143.62M | 89.64M | 89.28M |
| Total Assets | 9.18B | 8.55B | 8.19B | 7.63B | 6.30B | 5.84B | 5.92B | 5.83B | 5.71B | 5.67B | 5.81B | 5.52B |
| Accounts Payable | 470.30M | 423.55M | 479.04M | 383.68M | 360.78M | 364.50M | 405.00M | 307.53M | 333.02M | 356.57M | 315.11M | 341.86M |
| Short-Term Debt | 262.08M | 125.40M | 66.36M | 813.30M | 808.39M | 763.47M | 1.70B | 863.80M | 851.66M | 826.97M | 688.37M | 328.56M |
| Total Current Liabilities | 2.12B | 1.81B | 1.83B | 2.37B | 2.21B | 1.98B | 2.21B | 2.03B | 1.94B | 1.88B | 1.81B | 1.28B |
| Long-Term Debt | 882.16M | 962.51M | 961.91M | 832.75M | 146.09M | 160.16M | 166.48M | 187.51M | 185.27M | 199.03M | 197.62M | 202.49M |
| Total Liabilities | 4.00B | 3.79B | 3.83B | 3.50B | 2.53B | 2.34B | 2.59B | 2.39B | 2.35B | 2.31B | 2.27B | 1.76B |
| Shareholders' Equity | 5.17B | 4.76B | 4.36B | 4.13B | 3.77B | 3.50B | 3.33B | 3.44B | 3.37B | 3.36B | 3.54B | 3.76B |
| Retained Earnings | -7.86B | -8.09B | -8.32B | -8.39B | -8.51B | -8.61B | -8.61B | -8.45B | -8.33B | -8.21B | -7.96B | -7.59B |
| Total Debt | 1.14B | 1.09B | 1.03B | 1.65B | 954.49M | 923.63M | 1.87B | 1.05B | 1.04B | 1.03B | 885.98M | 531.05M |
| Net Cash (Debt) | 3.95B | 3.70B | 3.52B | 2.39B | 1.80B | 1.59B | 757.87M | 1.65B | 1.56B | 1.77B | 2.29B | 2.54B |
| Shares Outstanding | 1.47B | 1.44B | 1.44B | 1.44B | 1.43B | 1.40B | 1.39B | 1.39B | 1.38B | 1.36B | 1.36B | 1.35B |
This table shows 12 quarterly periods of BeOne Medicines's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ONC's reporting calendar. What is a balance sheet?